Who owns Oncolytics Biotech Inc?
- Ticker: ONCY
- CUSIP Number: 682310875
Tip: Access positions for across all investors
Analyze quarterly positions in Oncolytics Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Oncolytics Biotech stock
Who bought or sold Oncolytics Biotech Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Morgan Stanley | 348k | $369k | 457% | Mar 2024 |
|
| International Assets Investment Management | 202k | $214k | 1% | Mar 2024 |
|
| Citadel Advisors | 163k | $173k | 43% | Mar 2024 |
|
| Goldman Sachs Group | 84k | $89k | 100% | Mar 2024 |
|
| Commonwealth Equity Services | 63k | $67k | 13% | Mar 2024 |
|
| Royal Bank of Canada | 61k | $65k | 11% | Mar 2024 |
|
| CIBC World Markets | 58k | $62k | -5% | Mar 2024 |
|
| Virtu Financial | 52k | $55k | 100% | Mar 2024 |
|
| Geode Capital Management | 42k | $45k | 0% | Mar 2024 |
|
| Millennium Management | 41k | $43k | -68% | Mar 2024 |
|
| Long Focus Capital Management | 40k | $42k | 0% | Mar 2024 |
|
| Bank Of Montreal | 37k | $39k | -1% | Mar 2024 |
|
| Ausdal Financial Partners | 26k | $28k | -13% | Mar 2024 |
|
| Brave Asset Management | 25k | $27k | 0% | Mar 2024 |
|
| LPL Financial | 18k | $19k | -17% | Mar 2024 |
|
| C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors | 15k | $16k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 13k | $14k | 45% | Mar 2024 |
|
| Banque Cantonale Vaudoise | 12k | $13k | 0% | Mar 2024 |
|
| Two Sigma Securities | 12k | $13k | -49% | Mar 2024 |
|
| Headinvest | 12k | $16k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 12k | $12k | 0% | Mar 2024 |
|
| Kingsview Wealth Management | 11k | $12k | 0% | Mar 2024 |
|
| Scotia Capital | 11k | $14k | 100% | Dec 2023 |
|
| PFG Investments | 11k | $11k | 100% | Mar 2024 |
|
| Professional Advisory Services | 10k | $11k | 100% | Mar 2024 |
|
| Cedar Mountain Advisors | 5.7k | $6.0k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 4.4k | $4.7k | -6% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 3.7k | $4.9k | 1% | Dec 2023 |
|
| Federation des caisses Desjardins du Quebec | 3.3k | $4.7k | 100% | Mar 2024 |
|
| CWM | 2.3k | $2.0k | 0% | Mar 2024 |
|
| UBS Group | 1.2k | $1.2k | -75% | Mar 2024 |
|
| JNBA Financial Advisors | 210.00 | $222.999000 | 0% | Mar 2024 |
|
| Hobbs Group Advisors | 105.00 | $142.002000 | 100% | Dec 2023 |
|
| Wolff Wiese Magana | 31.00 | $32.999500 | 0% | Mar 2024 |
|
Who sold out of Oncolytics Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Advisor Resource Council | Dec 2023 | 100k | $135k |
| Newman Dignan & Sheerar | Dec 2023 | 22k | $30k |
| Bank of America Corporation | Dec 2023 | 6.1k | $8.2k |
| IFP Advisors | Sep 2023 | 2.0k | $4.4k |
| Barclays | Dec 2023 | 1.2k | $2.0k |
| TD Waterhouse Canada | Dec 2023 | 557.00 | $970.015500 |
| Planning Capital Management Corp | Dec 2023 | 215.00 | $291.002500 |
| Advisory Services Network | Dec 2023 | 100.00 | $135.000000 |
| Cypress Capital Management | Dec 2023 | 100.00 | $135.000000 |